Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 6;17(2):71-8.
doi: 10.1016/j.rpor.2012.01.002. eCollection 2012.

Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy)

Janka Carman  1 , Primož Strojan  1
Affiliations

Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy)

Janka Carman et al. Rep Pract Oncol Radiother. .

Abstract

Aim: To review the treatment results and identify prognostic factors for disease control and survival in a cohort of nasopharyngeal carcinoma (NPC) patients from a non-endemic population in Slovenia, diagnosed between 1990 and 2003.

Background: In Caucasians, nasopharyngeal carcinoma is a rare malignant tumor. Its diagnosis and treatment are complex and have been dramatically impacted by recent technological advances.

Materials and methods: In the Cancer Registry of Slovenia database, a total of 126 patients with NPC were identified, 93 of whom were available for analysis. All patients were treated with conventional two-dimensional radiotherapy (RT) and 29.3% underwent chemotherapy (ChT).

Results: The median follow-up time for those alive at the last follow-up examination was 74.5 months. Disease recurred locally in 17 patients, regionally in 4 patients and at distant sites in 18 patients, resulting in 5-year locoregional control (LRC), distant failure-free survival (DFFS) and disease-free survival (DFS) of 73.7%, 78.6% and 59.3%, respectively. Disease-specific survival at 5 years was 59% and overall survival (OS) was 49.7%. In a multivariate analysis, LRC was favorably affected (P < 0.05) by an undifferentiated histology (hazard ratio [HR] = 2.86), DFFS through the absence of neck metastases (HR = 0.28), DFS by younger age (HR = 0.46), and more intensive RT (expressed as the isoeffective dose, EQD2,T ; HR = 2.08). The independent prognosticator for OS was age (≤55 years vs. >55 years, HR = 0.39); in the ≤55 years subgroup, an improved OS was connected to a more intensive RT regimen of EQD2,T ≥ 66 Gy (HR = 4.17).

Conclusions: Our results confirm an independent and favorable effect from an undifferentiated histology, the absence of neck metastases, a younger patient age at diagnosis, and more intensive RT regimens for disease control and survival.

Keywords: Chemotherapy; Nasopharyngeal carcinoma; Prognostic factors; Radiotherapy; Survival.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Local, regional and distant control.
Fig. 2
Fig. 2
Patients ≤55 years of age: effect of intensity of radiotherapy (EQD2,T): A, disease-free survival; B, overall survival.
Fig. 3
Fig. 3
Salvage therapy for disease recurrence and outcome.
Fig. 4
Fig. 4
Disease-specific and overall survival.
See this image and copyright information in PMC

References

    1. Hu K.S., Chan A.T.C., Costantino P., Harrison L.B. Cancer of the nasopharynx. In: Harrison L.B., Sessions R.B., Hong W.K., editors. Head and neck cancer: a multidisciplinary approach. 3rd ed. Williams & Wilkins/Wolters Kluwer; Lippincott/Philadelphia: 2009. pp. 502–529.
    1. Cancer Registry of Slovenia. Cancer in Slovenia 1990–2003. Reports no. 32-45. Ljubljana: Institute of Oncology & Cancer Registry of Republic of Slovenia; 1993–2006.
    1. Chan A.T.C., Felip E., on behalf of the ESMO guidelines working group Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Suppl. 4):iv123–iv125. - PubMed
    1. Chan J.K.C., Bray F., McCarron P. Nasopharyngeal carcinoma. In: Barnes L., Eveson J.W., Reichart P., Sidransky D., editors. Pathology and genetics of head and neck tumors. IARC Press; Lyon: 2005. pp. 81–97.
    1. Sobin L.H., Wittekind C., editors. TNM classification of malignant tumours. 6th ed. Wiley Liss; New York: 2002. pp. 27–33.

LinkOut - more resources